SCHEMBL3296347

SCHEMBL3296347

CCOC(=O)c1cn(N(C)C)c2cc(O)ccc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.53
IRAK1 P51617 1/20 0.53
CAMK2B Q13554 1/20 0.53
CAMK2G Q13555 1/20 0.53
CAMK2D Q13557 1/20 0.53
PIM3 Q86V86 1/20 0.53
ROCK2 O75116 1/20 0.52
CDK1 P06493 1/20 0.52
PRKACA P17612 1/20 0.52
CDK2 P24941 1/20 0.52
CSNK1D P48730 1/20 0.52
GSK3A P49840 1/20 0.52
CDK5 Q00535 1/20 0.52
PRKCD Q05655 1/20 0.52
ROCK1 Q13464 1/20 0.52
CDC42BPA Q5VT25 1/20 0.52
MARK2 Q7KZI7 1/20 0.52
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7938747 0.84 TDP1 (0.52) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL4176910 0.82 LMNA (0.65) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL3296359 0.80 LMNA (0.52) LMNAKMT2AMEN1RAB9ATDP1
SCHEMBL3294927 0.80 LMNA (0.52) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL11077233 0.78 KDM4E (0.52) LMNAKMT2AMEN1TDP1POLB
SCHEMBL3291381 0.77 LMNA (0.47) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL3291387 0.77 LMNA (0.47) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL3291404 0.75 POLB (0.45) LMNAKMT2AMEN1RAB9AP2RX3
SCHEMBL5219407 0.75 LMNA (0.36) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL3291681 0.75 LMNA (0.47) LMNAKMT2AMEN1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718621-B2 Macrolones—amino substituted quinolones GLAXO GROUP LTD. (GB) 2010-05-18 US disclosed
US-20090062218-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2009-03-05 US disclosed
US-20080090773-A1 Macrolones - Amino Substituted Quinolones GLAXO GROUP LIMITED (GB) 2008-04-17 US disclosed
CN-101098881-A Macrolones - amino substituted quinolones GLAXO GROUP LTD (GB) 2008-01-02 CN disclosed
EP-1824870-A1 MACROLONES - AMINO SUBSTITUTED QUINOLONES GLAXO GROUP LIMITED (GB) 2007-08-29 EP disclosed
WO-2006050942-A1 MACROLONES - AMINO SUBSTITUTED QUINOLONES GLAXO GROUP LIMITED (GB) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062218-A1 MACROLONE COMPOUNDS CYP51A1, MRPL21, MYD88 PIM1 289/4885IRAK1 59/4885CAMK2B 4767/4885
US-20080090773-A1 Macrolones - Amino Substituted Quinolones MRPL21, Q6ZSR9, QARS1 PIM1 1484/4885IRAK1 1551/4885CAMK2B 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.